TS

Thilo Schroeder

Managing Partner at Nextech

Zurich, Zurich

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Education

Lists including Thilo

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

Alterome Therapeutics

Series A

Total Funding: $230M

FogPharma

Series E

Total Funding: $430M

Atavistik Bio

Series A

Total Funding: $100M

Exo Therapeutics

Series B

Total Funding: $78M

Silverback Therapeutics

Series B

Total Funding: $160M

Circle Pharma

Series B

Total Funding: $45M

Revolution Medicines

Series B

Total Funding: $180M

IDEAYA Biosciences

Series B

Total Funding: $140M

Blueprint Medicines

Series B

Total Funding: $65M

Work Experience

NI
Nextech Invest Ltd.

2012

  • Managing Partner

    2012

    The Global Oncology Investment Firm Industry: Venture Capital and Private Equity

ST
Synnovation Therapeutics

2023

  • Member Board of Directors

    2023

I
IDRx

2022

  • Board Observer

    2022

ET
Exo Therapeutics

2021

  • Board Member

    2021

AB
Atavistik Bio

2021

  • Member Board Of Directors

    2021

MT
MOMA Therapeutics

2020

  • Board Member

    2020

CP
Circle Pharma, Inc.

2020

  • Board Member

    2020

RM
REVOLUTION Medicines

2018

  • Member Board Of Directors

    2018

AT
Alterome Therapeutics, Inc

2022 - 2024

  • Member Board Of Directors

    2022 - 2024

MO
Mariana Oncology

2023 - 2024

  • Board Observer

    2023 - 2024